Today: 7 February 2026
Subscribe

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer Inc. (NYSE: PFE) is back in the headlines today with a flurry of developments that span new product launches, obesity-drug M&A, fresh vaccine data and ongoing debate about whether its battered stock is finally a buy. As of this afternoon, Pfizer shares are trading around $25.28, little changed on the day, and still down roughly 55% from their late‑2022 peak, leaving the dividend yield near the 7% level that has attracted income‑focused investors.sharewise.com+1 Below is a breakdown of the key Pfizer news and stock drivers for November 17, 2025. Market snapshot: PFE on November 17, 2025 Short‑term quantitative models
17 November 2025
···
GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

On Monday, November 17, 2025, GameStop (NYSE: GME) is back at the center of the market conversation as its share price hovers just above $20 while retail traders debate new lows, short‑squeeze odds, and the company’s latest viral promotion, “Trade Anything Day.” At the same time, analysts are re‑running their models on GameStop’s valuation after a profitable streak, Bitcoin‑linked treasury moves and a massive convertible note sale earlier this year. markets.businessinsider.com+2Simply Wall St+2 GME stock today: modest bounce after fresh 52‑week low In late‑morning trading on Monday, GameStop shares were changing hands around $20.7–$20.8, up a few tenths of a
17 November 2025
··
Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Let’s break down what’s locked in, what’s still just a proposal, and what it all means for your 2026 Social Security income as of today, November 17, 2025. 1. The 2026 COLA is official: 2.8% across Social Security and SSI On October 24, the Social Security Administration (SSA) confirmed that benefits will rise 2.8% in 2026, based on inflation as measured by the CPI‑W (Consumer Price Index for Urban Wage Earners and Clerical Workers). SSA According to SSA’s 2026 COLA fact sheet: Social Security The COLA is permanent. Once your benefit is adjusted upward, that higher base stays in place
17 November 2025
··
Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Automotive, Inc. (NASDAQ: RIVN) is having another eventful Monday. After a huge post‑earnings rally, the electric‑vehicle maker is now caught between bullish Wall Street upgrades, negative headlines about a battery‑calibration problem, and fresh disclosures showing big investors trimming their stakes. As of early afternoon on November 17, Rivian stock is trading around $15.06, down slightly on the day after last week’s surge. The stock remains up strongly over the past month thanks to a surprise move into positive gross profit in Q3 2025 and a series of upbeat analyst notes.Blockonomi+1 Key Takeaways Rivian Stock Price Today: Cooling After a
17 November 2025
····
Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) stock edges higher on November 17, 2025 as Elon Musk accelerates a shift away from China-made parts, Peter Thiel slashes his stake, AI5 chip timelines slip, and analysts clash over robotaxi upside vs. “tough reality.” TSLA stock today: rebound after a choppy stretch As of mid‑afternoon on November 17, 2025, Tesla shares trade near $414.46, up about 2.5% on the day, with intraday moves between roughly $397 and $415. Volume is elevated relative to normal sessions. This bounce comes after a sharp pullback from recent 52‑week highs above $480, driven by: At today’s price, multiple independent analyses still
17 November 2025
···
Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Motor Company (NYSE: F) has quietly become one of 2025’s unlikeliest comeback stories. After years of a sluggish share price, the stock is up roughly one‑third this year, outpacing the broader market, even as its electric‑vehicle unit bleeds billions of dollars. Fresh reports and analyst notes published today, 17 November 2025, show why Wall Street is suddenly “in love” with Ford again — and why the story is more complicated than a simple turnaround. 24/7 Wall St.+1 Key Takeaways A 2025 Rally That Leaves the S&P 500 Behind Ford’s stock has staged a powerful comeback this year. According to
17 November 2025
···
Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Pfizer’s acquisition of Metsera, Inc. (formerly NASDAQ: MTSR) is now effectively complete, Metsera’s stock has been delisted, major index providers are removing the name, and antitrust scholars are using the failed Novo Nordisk bid as a case study in “attempted monopolization.” Here’s a full rundown of what matters today, 17 November 2025, for anyone following Metsera, MTSR, or the obesity‑drug arms race. 1. Where the Metsera–Pfizer Deal Stands Today Pfizer formally closed its acquisition of Metsera on November 13, 2025, after Metsera shareholders approved a sweetened offer that values the obesity biotech at up to $10 billion.Reuters+1 Key terms of
17 November 2025
···
Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies (NASDAQ: OPEN) is back in the spotlight as a controversial warrant dividend aimed at short sellers dominates headlines, even as Morgan Stanley reiterates a Hold rating and quants flag huge hedge fund flows. Here’s everything investors need to know about OPEN on November 17, 2025. Market snapshot: OPEN stock today As of this afternoon on November 17, 2025, Opendoor Technologies Inc. (NASDAQ: OPEN) is trading around $8.03, down roughly 1% on the day after an explosive run that recently sent the stock above $10. Despite today’s mild pullback, OPEN remains: At the center of today’s news cycle: Opendoor’s
17 November 2025
··
Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings Inc. (NASDAQ: ONDS), a provider of autonomous drone systems and private wireless networks, packed several major announcements into Monday, November 17, 2025 – including a new multimillion‑dollar European airport contract, the closing of a $225 million acquisition, and fresh bullish analyst signals. Stock Titan Together, the developments underscore how aggressively Ondas is positioning itself at the center of the global counter‑drone and autonomous defense market. Key takeaways for November 17, 2025 As of the latest intraday data on November 17, 2025, ONDS was trading around $7.00 per share, down roughly 2.5% on the day after a sharp run‑up
17 November 2025
···
Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder, Inc. (ASX: LNW, formerly NASDAQ: LNW) has hit a turning point this week. As of 17 November 2025, the cross‑platform gaming group has fully completed its move to a sole listing on the Australian Securities Exchange (ASX), shifted its US$1.5 billion share buyback onto the Australian market, and attracted fresh attention from both institutional investors and brokers. AGB Today’s key Light & Wonder headlines (17 November 2025) ASX‑only listing now in effect Light & Wonder has spent months preparing to exit Nasdaq and concentrate trading on the ASX. The company first notified Nasdaq of its intention to
17 November 2025
···
Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat, Inc. (NASDAQ: BYND) is back in the spotlight today as fresh legal scrutiny, shifting short interest, and lingering questions about its debt restructuring collide with a battered share price hovering just above the $1 mark. As of today, Beyond Meat stock is trading around $1.08, giving the plant-based meat maker a market cap of roughly $490 million, a dramatic comedown from its 2019 IPO glory days. Google+2 1. New Securities-Fraud Investigation Announced This Morning The headline news for November 17, 2025 is a fresh securities-fraud class action investigation into Beyond Meat by law firm Bleichmar Fonti & Auld
17 November 2025
····
Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) moved sharply higher today after the company confirmed that TONMYA™ (cyclobenzaprine HCl sublingual tablets), its newly approved fibromyalgia treatment, is now commercially available by prescription across the United States.GlobeNewswire+1 TONMYA Officially Launches in the U.S. Tonix announced at 7:00 a.m. EST that TONMYA is available for pharmacy ordering nationwide and can now be prescribed for adults with fibromyalgia.GlobeNewswire The drug is: TONMYA became the first new FDA‑approved therapy for fibromyalgia in more than 15 years when regulators cleared it on August 15, 2025, based on two pivotal Phase 3 trials involving nearly 1,000 patients.Tonix
17 November 2025
·
1 … 2,147 2,148 2,149 2,150 2,151 … 2,707

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop